These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

296 related items for PubMed ID: 31653343

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Endonuclease VIII-like 1 deficiency potentiates nigrostriatal dopaminergic neuron degeneration in a male mouse model of Parkinson's disease.
    Chen YH, Kuo YY, You YQ, Lin YT, Chen PC.
    J Neurochem; 2023 Jun; 165(5):741-755. PubMed ID: 36840377
    [Abstract] [Full Text] [Related]

  • 3. Comparison of the effect of rotenone and 1‑methyl‑4‑phenyl‑1,2,3,6‑tetrahydropyridine on inducing chronic Parkinson's disease in mouse models.
    Zhang J, Sun B, Yang J, Chen Z, Li Z, Zhang N, Li H, Shen L.
    Mol Med Rep; 2022 Mar; 25(3):. PubMed ID: 35039876
    [Abstract] [Full Text] [Related]

  • 4. TRPV4 contributes to ER stress and inflammation: implications for Parkinson's disease.
    Liu N, Bai L, Lu Z, Gu R, Zhao D, Yan F, Bai J.
    J Neuroinflammation; 2022 Jan 29; 19(1):26. PubMed ID: 35093118
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Dopaminergic neuron-specific deletion of p53 gene is neuroprotective in an experimental Parkinson's disease model.
    Qi X, Davis B, Chiang YH, Filichia E, Barnett A, Greig NH, Hoffer B, Luo Y.
    J Neurochem; 2016 Sep 29; 138(5):746-57. PubMed ID: 27317935
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Comparison of the neuroprotective potential of Mucuna pruriens seed extract with estrogen in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced PD mice model.
    Yadav SK, Prakash J, Chouhan S, Westfall S, Verma M, Singh TD, Singh SP.
    Neurochem Int; 2014 Jan 29; 65():1-13. PubMed ID: 24333323
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Loss of collapsin response mediator protein 4 suppresses dopaminergic neuron death in an 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced mouse model of Parkinson's disease.
    Tonouchi A, Nagai J, Togashi K, Goshima Y, Ohshima T.
    J Neurochem; 2016 Jun 29; 137(5):795-805. PubMed ID: 26991935
    [Abstract] [Full Text] [Related]

  • 12. MicroRNA-124 regulates the expression of p62/p38 and promotes autophagy in the inflammatory pathogenesis of Parkinson's disease.
    Yao L, Zhu Z, Wu J, Zhang Y, Zhang H, Sun X, Qian C, Wang B, Xie L, Zhang S, Lu G.
    FASEB J; 2019 Jul 29; 33(7):8648-8665. PubMed ID: 30995872
    [Abstract] [Full Text] [Related]

  • 13. Systemically administered neuregulin-1β1 rescues nigral dopaminergic neurons via the ErbB4 receptor tyrosine kinase in MPTP mouse models of Parkinson's disease.
    Depboylu C, Rösler TW, de Andrade A, Oertel WH, Höglinger GU.
    J Neurochem; 2015 May 29; 133(4):590-7. PubMed ID: 25581060
    [Abstract] [Full Text] [Related]

  • 14. Glimepiride Prevents 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine Induced Dopamine Neurons Degeneration Through Attenuation of Glia Activation and Oxidative Stress in Mice.
    Oduola-Akande MD, Ishola IO, Olubodun-Obadun TG, Akande AJ, Adeyemi OO.
    Neurotox Res; 2023 Jun 29; 41(3):212-223. PubMed ID: 36705862
    [Abstract] [Full Text] [Related]

  • 15. Treadmill exercise produces neuroprotective effects in a murine model of Parkinson's disease by regulating the TLR2/MyD88/NF-κB signaling pathway.
    Koo JH, Jang YC, Hwang DJ, Um HS, Lee NH, Jung JH, Cho JY.
    Neuroscience; 2017 Jul 25; 356():102-113. PubMed ID: 28527958
    [Abstract] [Full Text] [Related]

  • 16. Inhibition of the hepatic Nlrp3 protects dopaminergic neurons via attenuating systemic inflammation in a MPTP/p mouse model of Parkinson's disease.
    Qiao C, Zhang Q, Jiang Q, Zhang T, Chen M, Fan Y, Ding J, Lu M, Hu G.
    J Neuroinflammation; 2018 Jul 02; 15(1):193. PubMed ID: 29966531
    [Abstract] [Full Text] [Related]

  • 17. Connexin 30 deficiency attenuates A2 astrocyte responses and induces severe neurodegeneration in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine hydrochloride Parkinson's disease animal model.
    Fujita A, Yamaguchi H, Yamasaki R, Cui Y, Matsuoka Y, Yamada KI, Kira JI.
    J Neuroinflammation; 2018 Aug 13; 15(1):227. PubMed ID: 30103794
    [Abstract] [Full Text] [Related]

  • 18. Intervention with exercise restores motor deficits but not nigrostriatal loss in a progressive MPTP mouse model of Parkinson's disease.
    Sconce MD, Churchill MJ, Greene RE, Meshul CK.
    Neuroscience; 2015 Jul 23; 299():156-74. PubMed ID: 25943481
    [Abstract] [Full Text] [Related]

  • 19. Protective role of SIRT5 against motor deficit and dopaminergic degeneration in MPTP-induced mice model of Parkinson's disease.
    Liu L, Peritore C, Ginsberg J, Shih J, Arun S, Donmez G.
    Behav Brain Res; 2015 Mar 15; 281():215-21. PubMed ID: 25541039
    [Abstract] [Full Text] [Related]

  • 20. 1-Methyl-4-phenyl-1,2,3,6 tetrahydropyridine/probenecid impairs intestinal motility and olfaction in the early stages of Parkinson's disease in mice.
    Choi JG, Huh E, Ju IG, Kim N, Yun J, Oh MS.
    J Neurol Sci; 2018 Sep 15; 392():77-82. PubMed ID: 30031172
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.